Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to si... Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402. Mehr anzeigen
Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), advancing in two late-stage, registrational clinical trials in two indications Phase 3 sunRIZE study...
REDWOOD CITY, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company dedicated to developing transformative...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.03 | -0.60120240481 | 4.99 | 5.14 | 4.68 | 297122 | 4.89833066 | CS |
| 4 | -0.72 | -12.676056338 | 5.68 | 6.1856 | 4.66 | 366905 | 5.35908265 | CS |
| 12 | 0.27 | 5.75692963753 | 4.69 | 6.1856 | 4.12 | 412395 | 5.1301175 | CS |
| 26 | 1.34 | 37.0165745856 | 3.62 | 6.1856 | 3.4 | 421997 | 4.76970643 | CS |
| 52 | 4.16 | 520 | 0.8 | 6.1856 | 0.72 | 394845 | 3.60476079 | CS |
| 156 | -0.24 | -4.61538461538 | 5.2 | 6.1856 | 0.72 | 177553 | 3.42999324 | CS |
| 260 | -15.18 | -75.3723932473 | 20.14 | 21.2 | 0.72 | 141539 | 3.84009531 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
